|
Synonyms: JM-8 | Paraplatin®
carboplatin is an approved drug (FDA (1989))
Compound class:
Inorganic
Comment: Carboplatin is a platinum-based chemotherapy drug.
|
Classification  |
|
| Compound class | Inorganic |
| Approved drug? | Yes (FDA (1989)) |
| WHO Essential Medicine | WHO Essential Medicines List (EML) (23rd List, 2023). Access PDF version. Click to view more information about the WHO Model Lists of Essential Medicines. |
| International Nonproprietary Names |
|
| INN number | INN |
| 5231 | carboplatin |
| Synonyms |
| JM-8 | Paraplatin® |
| Database Links |
|
| CAS Registry No. | 41575-94-4 |
| ChEMBL Ligand | CHEMBL1351 |
| GtoPdb PubChem SID | 223365959 |
| PubChem CID | 10339178 |
| Search PubMed clinical trials | carboplatin |
| Search PubMed titles | carboplatin |
| Search PubMed titles/abstracts | carboplatin |
| Wikipedia | Carboplatin |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Carboplatin (links to external site)
Cat. No. 2626 |
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License
